NTRB

Nutriband Inc
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$36.83M
P/E Ratio
EPS
$-2.56
Beta
1.94
52W High
$9.21
52W Low
$2.90
50-Day MA
$3.48
200-Day MA
$4.70
Dividend Yield
Profit Margin
0.00%
Forward P/E
370.37
PEG Ratio

About Nutriband Inc

Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.

Official WebsiteUSAFY End: January

Fundamentals

Revenue (TTM)$1.80M
Gross Profit (TTM)511,130
EBITDA$-7.99M
Operating Margin-289.40%
Return on Equity-145.70%
Return on Assets-78.20%
Revenue/Share (TTM)$0.15
Book Value$0.49
Price-to-Book6.21
Price-to-Sales (TTM)20.43
EV/Revenue18.54
EV/EBITDA-4.55
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-35.10%
Shares Outstanding$12.16M
Float$5.28M
% Insiders56.81%
% Institutions3.08%

Historical Volatility

HV 10-Day
46.39%
HV 20-Day
58.19%
HV 30-Day
55.55%
HV 60-Day
53.08%
HV Rank
21.8%

Volatility is currently contracting

Latest News

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Nutriband's Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers ORLANDO, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) and its wholly owned subsidiary Active Intelligence (“Active Intelligence” or the “Company”), an emerging leader in innovative wellness, recovery, and performance-focused consumer products, today announced its participation in the upcoming ECRM conference taking place in June 2026, where the Company will showcase its latest AI-branded product portfolio to buyers and executives from some of the nation's largest retail and healthcare organizations.

GlobeNewsWire5/15/2026Neutral
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

ORLANDO, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan has featured on the latest episode of the Jack Neel Podcast to discuss the opioid crisis, the Company's AVERSA technology and the opportunity for Nutriband to improve the safety profile of easily abused medications.

GlobeNewsWire4/22/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026